Tysabri (natalizumab) is a medication primarily approved for treating relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS). It is not generally indicated for non-active or inactive SPMS. The key factor in its…
Tysabri (natalizumab) is a medication used to treat multiple sclerosis (MS), primarily known for its ability to reduce relapses and slow physical disability progression. When it comes to cognitive function in MS, the question of whether Tysabri improves cognition is…
The risk of JC virus infection with Tysabri (natalizumab) centers primarily on the development of a rare but serious brain infection called progressive multifocal leukoencephalopathy (PML). PML is caused by reactivation of the John Cunningham virus (JC virus), which is…
Tysabri (natalizumab) is a powerful medication used to treat multiple sclerosis (MS), particularly in patients with relapsing forms of the disease. It works by blocking immune cells from crossing into the brain and spinal cord, thereby reducing inflammation and preventing…
Tysabri (natalizumab) is a medication used primarily to treat multiple sclerosis (MS), a chronic disease affecting the central nervous system. When it comes to whether Tysabri causes depression or anxiety, the relationship is complex and not entirely straightforward. Tysabri itself…
Gilenya (generic name fingolimod) **continues to be prescribed in 2025** as a treatment for relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS in patients aged 10 years and older. It remains…
Gilenya, whose generic name is fingolimod, is a medication used to treat multiple sclerosis (MS), particularly relapsing forms of the disease. One of the key concerns in MS management is controlling and reducing lesions in the brain and spinal cord…
Gilenya, whose generic name is fingolimod, is a medication primarily used to treat multiple sclerosis (MS). One of the important considerations when starting Gilenya treatment is its effect on the heart, particularly regarding heart rhythm. Yes, Gilenya can cause irregular…
If Gilenya (fingolimod) is stopped abruptly, several important effects and risks can occur, primarily related to the return or worsening of multiple sclerosis (MS) symptoms and potential rebound disease activity. Gilenya works by modulating the immune system, specifically by lowering…
Gilenya, also known as fingolimod, is a medication used to treat multiple sclerosis (MS), particularly relapsing forms of the disease. It works by trapping certain immune cells in lymph nodes, preventing them from reaching the central nervous system where they…